MS
Md Sarifur Rahman
About Md Sarifur Rahman
Data last updated:
Md Sarifur Rahman is a Director at Arthy Learning And Implementation Private Limited (since 2017), Director at Recan Pharma Private Limited (since 2022) and Director at Nesta Gyan Private Limited (since 2019). The companies operate in Business Services, E-Commerce and Education & Learing. The largest current company by reported revenue is Arthy Learning And Implementation Private Limited at ₹74.8 Lakh (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Jun 2017 | 2017 | ₹74.8 Lakh (FY 2020) | Active | |
| Director | 14 Dec 2022 | 2022 | Active | ||
| Director | 27 Aug 2019 | 2019 | Active |
Board colleagues of Md Sarifur Rahman
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashik Faraji | 07808887 | Arthy Learning And Implementation Private Limited , Nesta Gyan Private Limited | Director |
| Monsur Ahmed | 09824517 | Recan Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Md Sarifur Rahman
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Md Sarifur Rahman
Md Sarifur Rahman currently holds 3 directorships: Arthy Learning And Implementation Private Limited (Director, since 06 Jun 2017, revenue ₹74.8 Lakh (FY 2020)); Recan Pharma Private Limited (Director, since 14 Dec 2022); Nesta Gyan Private Limited (Director, since 27 Aug 2019).
Md Sarifur Rahman was first appointed on 06 Jun 2017 as Director at Arthy Learning And Implementation Private Limited. The most recent appointment on record is 14 Dec 2022 at Recan Pharma Private Limited.
The current boards of Md Sarifur Rahman's companies include Ashik Faraji (Arthy Learning And Implementation Private Limited), Monsur Ahmed (Recan Pharma Private Limited).